Home › Non-Muscle Invasive Bladder Cancer › Massachusetts
Non-Muscle Invasive Bladder Cancer clinical trials in Massachusetts
10 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in Massachusetts.
Cities in Massachusetts
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Brigham and Women's Hospital, Boston
- Lahey Clinic, Burlington
- Lahey Clinic Peabody, Peabody
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07000084Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
- Greater Boston Urology, Plymouth
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT06995677A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Greater Boston Urology, Plymouth
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06919965Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
- VA Boston Jamaica Plains Campus, West Roxbury
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT05796375Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Brigham and Women's Hospital, Boston
- Greater Boston Urology, LLC, Plymouth
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Massachusetts General Hospital, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05614739A Phase I Intravesical PPM Therapy for NMIBC
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05519241LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Brigham and Women's Hospital, Boston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT04752722A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
- Brigham and Women's Hospital, Boston
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 27, 2026 · NCT05710848Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
- Lahey Hospital and Medical Center, Burlington
Recruiting
Ages 18 and older · All sexes · Updated Sep 22, 2025 · NCT07187063From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.